Atlas Trials

Convalife (Shanghai) Co., Ltd.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Convalife (Shanghai) Co., Ltd.

RecordFirmDate
Clinical Study of CVL006 Combination With 9MW2821 (NCT07615660)Convalife (Shanghai) Co., Ltd.2026-05-15
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression (NCT07446049)Convalife (Shanghai) Co., Ltd.2026-05-01
CVL006 Combination Therapy in Advanced Solid Tumors (NCT07157956)Convalife (Shanghai) Co., Ltd.2025-09-10
Clinical Study of CVL006 Injection in Advanced Solid Tumors (NCT06621615)Convalife (Shanghai) Co., Ltd.2024-11-20
Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations (NCT06519110)Convalife (Shanghai) Co., Ltd.2024-08-10
Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases (NCT06374888)Convalife (Shanghai) Co., Ltd.2024-04-30
CVL237 Tablets for APDS/PASLI (NCT06293716)Convalife (Shanghai) Co., Ltd.2024-03-30
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency (NCT06183736)Convalife (Shanghai) Co., Ltd.2023-12-20
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations (NCT06029816)Convalife (Shanghai) Co., Ltd.2023-11-20

Track Convalife (Shanghai) Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.